Charlottte (Talk | contribs) |
Charlottte (Talk | contribs) |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | + | ||
<html> | <html> | ||
<head> | <head> | ||
Line 7: | Line 7: | ||
<meta name="author" content="scut_lyj"> | <meta name="author" content="scut_lyj"> | ||
<title>IGEM-China_B</title> | <title>IGEM-China_B</title> | ||
− | <style | + | <style> |
− | + | body { | |
margin:0px; | margin:0px; | ||
background-position:0px 15px; | background-position:0px 15px; | ||
+ | background-size:2px 4000px; | ||
background-repeat:repeat-x; | background-repeat:repeat-x; | ||
background-attachment:scroll; | background-attachment:scroll; | ||
− | |||
position:relative; | position:relative; | ||
− | + | width:1600px; | |
− | width: | + | |
margin-left:auto; | margin-left:auto; | ||
margin-right:auto; | margin-right:auto; | ||
− | + | left:-50px; | |
+ | } | ||
+ | #content { | ||
+ | width:100%; | ||
+ | background-position:left top; | ||
+ | background-repeat:repeat-x; | ||
+ | background-attachment:scroll; | ||
+ | background-size:2px 6654px; | ||
} | } | ||
− | |||
#firstHeading { | #firstHeading { | ||
Line 53: | Line 58: | ||
display:none; | display:none; | ||
} | } | ||
+ | |||
* { | * { | ||
margin:0; | margin:0; | ||
Line 132: | Line 138: | ||
.nav { | .nav { | ||
position:relative; | position:relative; | ||
− | width: | + | width: 103%; |
text-align: center; | text-align: center; | ||
} | } | ||
Line 138: | Line 144: | ||
.nav ul { | .nav ul { | ||
height:0; | height:0; | ||
− | |||
overflow:hidden; | overflow:hidden; | ||
position:absolute; | position:absolute; | ||
width: 100%; | width: 100%; | ||
box-shadow: 1px 1px 1px #c94856; | box-shadow: 1px 1px 1px #c94856; | ||
+ | margin: 0!important; | ||
} | } | ||
.nav li{ | .nav li{ | ||
Line 260: | Line 266: | ||
.article { | .article { | ||
background-color: white; | background-color: white; | ||
− | width: | + | width: 60%; |
− | + | margin-left: 15%; | |
− | margin-left: | + | |
margin-top: 0; | margin-top: 0; | ||
padding-top: 5px; | padding-top: 5px; | ||
Line 339: | Line 344: | ||
90 | 90 | ||
} | } | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
.disc { | .disc { | ||
width: 75%; | width: 75%; | ||
Line 363: | Line 365: | ||
display: block; | display: block; | ||
} | } | ||
+ | .bar { | ||
+ | position: fixed; | ||
+ | width: 12.8%; | ||
+ | height: auto; | ||
+ | float: right; | ||
+ | cursor: pointer; | ||
+ | top: 25%; | ||
+ | right: 2.2%; | ||
+ | text-align: center; | ||
+ | font-size: 16px; | ||
+ | line-height: 24px; | ||
+ | box-shadow: 5px 5px #ffc7e4; | ||
+ | } | ||
+ | .Ltitle { | ||
+ | width: 100%; | ||
+ | height: auto; | ||
+ | background-color: #d6515c; | ||
+ | padding-bottom: 10px; | ||
+ | line-height: 28px; | ||
+ | } | ||
+ | .Mtitle { | ||
+ | width: 100%; | ||
+ | height: auto; | ||
+ | } | ||
+ | .Stitle { | ||
+ | width: 100%; | ||
+ | transition: 1s; | ||
+ | -moz-transition: 1s; | ||
+ | -o-transition: 1s; | ||
+ | -webkit-transition: 1s; | ||
+ | opacity:0; | ||
+ | line-height: 1px; | ||
+ | } | ||
+ | .Ltitle:hover { | ||
+ | background-image: -webkit-gradient(linear, 0% 0%, 0% 95%, from(rgba(206,15,53, 0.5)), to(rgba(255,255,255, 0))); | ||
+ | background-image: -moz-linear-gradient(-90deg, rgba(206,15,53, 0.5), rgba(206,15,53, 0)); | ||
+ | background-image: -o-linear-gradient(-90deg,rgba(206,15,53,0.5),rgba(206,15,53,0)); | ||
+ | } | ||
+ | .Mtitle:hover { | ||
+ | background-image: -webkit-gradient(linear, 0% 0%, 0% 95%, from(rgba(206,15,53, 0.5)), to(rgba(255,255,255, 0))); | ||
+ | background-image: -moz-linear-gradient(-90deg, rgba(206,15,53, 0.5), rgba(206,15,53, 0)); | ||
+ | background-image: -o-linear-gradient(-90deg,rgba(206,15,53,0.5),rgba(206,15,53,0)); | ||
+ | } | ||
+ | .Stitle:hover { | ||
+ | background-image: -webkit-gradient(linear, 0% 0%, 0% 95%, from(rgba(206,15,53, 0.5)), to(rgba(255,255,255, 0))); | ||
+ | background-image: -moz-linear-gradient(-90deg, rgba(206,15,53, 0.5), rgba(206,15,53, 0)); | ||
+ | background-image: -o-linear-gradient(-90deg,rgba(206,15,53,0.5),rgba(206,15,53,0)); | ||
+ | } | ||
+ | .Ltitle:hover .Stitle { | ||
+ | opacity:1; | ||
+ | line-height: 42px; | ||
+ | -moz-transition-delay:0s; | ||
+ | -o-transition-delay:0s; | ||
+ | -webkit-transition-delay:0s; | ||
+ | transition-delay:0s; | ||
+ | height: auto; | ||
+ | } | ||
+ | .bar a { | ||
+ | color: white; | ||
+ | } | ||
+ | |||
</style> | </style> | ||
</head> | </head> | ||
<body> | <body> | ||
<div class="nav"> | <div class="nav"> | ||
− | <li><img src="https://static.igem.org/mediawiki/parts/3/3b/Wiki_logo.png" alt="logo" class="logo1"></li> | + | <li style="width:10%;"><img src="https://static.igem.org/mediawiki/parts/3/3b/Wiki_logo.png" alt="logo" class="logo1"></li> |
<li><img src="https://static.igem.org/mediawiki/parts/6/6a/Wiki_4.png" alt="logo" class="logo2"></li> | <li><img src="https://static.igem.org/mediawiki/parts/6/6a/Wiki_4.png" alt="logo" class="logo2"></li> | ||
− | <li><a href="../ | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B">Home</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Overview">Project</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Overview">Overview</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Propoptosis">Apoptosis Induction</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Protumor">Tumor specific promoter</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href="">Achievements</a> | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Results">Achievements</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href="">Results</a></li> | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Results">Results</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Parts">Parts</a></li> |
+ | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Judging">Judging</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Modeling">Modeling</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Apoptosis">Apoptosis</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Crispri">CRISPRi/a</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href="">Notebook</a> | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Protocol">Notebook</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Protocol">Protocol</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Safety">Safety</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/HP/Gold">Human Practice</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/HP/Gold">Overview</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/HP/HP1">Project Design</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/HP/HP2">Public Outreach</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/HP/HP3">Hospice Care</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
− | <li><a href="">Lab</a> | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Team">Lab</a> |
− | <ul> | + | <ul class="ultop"> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Team">Team</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Collaborations">Collaborations</a></li> |
− | <li><a href=" | + | <li><a href="https://2016.igem.org/Team:SCUT-China_B/Attributions">Attributions</a></li> |
</ul> | </ul> | ||
</li> | </li> |
Latest revision as of 18:39, 28 November 2016
Nanjing University
We worked with Nanjing University in the model of tumor metastasis. We assisted them in implementing the tumor metastasis model in Matlab and analyzed the parameters in the model .To see Nanjing University's models, click here.
Beijing Institute of Technology
We have given amendment opinions to Bit team about their origin model. To see BIT’s models, click here.
And Bit team created an app for us to arrange our time to do experiments, which help us improve the efficiency in lab.